-
-
-
-
-
-
-
Truist Securities Reiterates Buy Rating on RadNet (RDNT)
-
-
-
-
-
-
-
RadNet's AI breast cancer screening shows 21.6% detection boost
-
-
-
-
-
-
-
RadNet (RDNT) PT Raised to $75 at Raymond James
-
-
-
-
-
-
-
RadNet (RDNT) Acquires See-Mode Technologies
-
-
-
-
-
-
-
RadNet (RDNT) PT Lowered to $76 at Jefferies
-
-
-
-
-
-
-
RadNet's (RDNT) DeepHealth Subsidiary Expands FDA Clearance for SmartMammo Solution
-
-
-
-
-
-
-
Barclays Upgrades RadNet (RDNT) to Overweight
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

